Longer reproductive window could up risk for Alzheimer’s disease
Jul 12, 2021
The authors suggest that longer exposure to endogenous estrogen may be associated with increased levels of Alzheimer’s disease biomarkers.
Lilly to seek FDA approval for new drug for Alzheimer’s disease
Jun 25, 2021
Donanemab already has received a ‘breakthrough therapy’ designation from the FDA.
Retinal layer thickness linked to cognitive decline in older adults
May 27, 2022
Thinner baseline total macular retinal nerve fiber layer thickness was associated with a larger decline in cognitive function test scores during follow-up.